BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24595605)

  • 1. Human serum albumin binding to silica nanoparticles--effect of protein fatty acid ligand.
    Ang JC; Henderson MJ; Campbell RA; Lin JM; Yaron PN; Nelson A; Faunce T; White JW
    Phys Chem Chem Phys; 2014 Jun; 16(21):10157-68. PubMed ID: 24595605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR identification of endogenous metabolites interacting with fatted and non-fatted human serum albumin in blood plasma: Fatty acids influence the HSA-metabolite interaction.
    Jupin M; Michiels PJ; Girard FC; Spraul M; Wijmenga SS
    J Magn Reson; 2013 Mar; 228():81-94. PubMed ID: 23357430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative studies of unfolding and binding of ligands to human serum albumin in the presence of fatty acid: spectroscopic approach.
    Varshney A; Ahmad B; Khan RH
    Int J Biol Macromol; 2008 Jun; 42(5):483-90. PubMed ID: 18452986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urea and acid induced unfolding of fatted and defatted human serum albumin.
    Salahuddin P
    Protein Pept Lett; 2008; 15(8):826-33. PubMed ID: 18855756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long chain fatty acids alter the interactive binding of ligands to the two principal drug binding sites of human serum albumin.
    Yamasaki K; Hyodo S; Taguchi K; Nishi K; Yamaotsu N; Hirono S; Chuang VTG; Seo H; Maruyama T; Otagiri M
    PLoS One; 2017; 12(6):e0180404. PubMed ID: 28662200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR metabolomics profiling of blood plasma mimics shows that medium- and long-chain fatty acids differently release metabolites from human serum albumin.
    Jupin M; Michiels PJ; Girard FC; Spraul M; Wijmenga SS
    J Magn Reson; 2014 Feb; 239():34-43. PubMed ID: 24374750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relaxometric and modelling studies of the binding of a lipophilic Gd-AAZTA complex to fatted and defatted human serum albumin.
    Gianolio E; Giovenzana GB; Longo D; Longo I; Menegotto I; Aime S
    Chemistry; 2007; 13(20):5785-97. PubMed ID: 17407109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel insights into the pleiotropic effects of human serum albumin in health and disease.
    Ha CE; Bhagavan NV
    Biochim Biophys Acta; 2013 Dec; 1830(12):5486-93. PubMed ID: 23602811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular dynamics study of conformational changes in human serum albumin by binding of fatty acids.
    Fujiwara S; Amisaki T
    Proteins; 2006 Aug; 64(3):730-9. PubMed ID: 16783783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-angle neutron scattering study of differences in phase behavior of silica nanoparticles in the presence of lysozyme and bovine serum albumin proteins.
    Yadav I; Kumar S; Aswal VK; Kohlbrecher J
    Phys Rev E Stat Nonlin Soft Matter Phys; 2014 Mar; 89(3):032304. PubMed ID: 24730839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis.
    Simard JR; Zunszain PA; Hamilton JA; Curry S
    J Mol Biol; 2006 Aug; 361(2):336-51. PubMed ID: 16844140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of interfacial water on protein adsorption at cross-linked polyethylene oxide interfaces.
    Leung BO; Yang Z; Wu SS; Chou KC
    Langmuir; 2012 Apr; 28(13):5724-8. PubMed ID: 22390193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and spectroscopic studies of resveratrol aliphatic acid ligands of human serum albumin.
    Jiang YL
    Bioorg Med Chem; 2008 Jun; 16(12):6406-14. PubMed ID: 18499462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin.
    Bhattacharya AA; Grüne T; Curry S
    J Mol Biol; 2000 Nov; 303(5):721-32. PubMed ID: 11061971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites.
    Curry S; Mandelkow H; Brick P; Franks N
    Nat Struct Biol; 1998 Sep; 5(9):827-35. PubMed ID: 9731778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding to human serum albumin of zidovudine (AZT) and novel AZT derivatives. Experimental and theoretical analyses.
    Quevedo MA; Ribone SR; Moroni GN; Briñón MC
    Bioorg Med Chem; 2008 Mar; 16(6):2779-90. PubMed ID: 18249551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty acid binding to serum albumin: molecular simulation approaches.
    Fujiwara S; Amisaki T
    Biochim Biophys Acta; 2013 Dec; 1830(12):5427-34. PubMed ID: 23567799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albumin removal from human serum using surface nanopockets on silica-coated magnetic nanoparticles.
    Bhakta S; Dixit CK; Bist I; Macharia J; Shen M; Kadimisetty K; He J; Dutta B; Suib SL; Rusling JF
    Chem Commun (Camb); 2017 Aug; 53(66):9254-9257. PubMed ID: 28770934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle size and production efficiency are affected by the presence of fatty acids during albumin nanoparticle fabrication.
    Luebbert CC; Clarke TM; Pointet R; Frahm GE; Tam S; Lorbetskie B; Sauvé S; Johnston MJW
    PLoS One; 2017; 12(12):e0189814. PubMed ID: 29281685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of sulfhydryl-reactive silica for protein immobilization in high-performance affinity chromatography.
    Mallik R; Wa C; Hage DS
    Anal Chem; 2007 Feb; 79(4):1411-24. PubMed ID: 17297940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.